company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,171244000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,171244000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19750000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19750000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,151494000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26523000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,24403000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20871000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1278000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73075000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78419000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,187000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2431000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1644000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,600000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,79019000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27502000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51517000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51517000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,371000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51146000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113261000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115528000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.44
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2009.0,Q3,2009-03-28,2009-06-26,2010-07-29 16:18:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,221216000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,221216000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35793000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35793000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,185423000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27882000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,30384000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22800000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,185000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81251000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,104172000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1832000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,460000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2207000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,106379000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36886000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69493000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,69493000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,407000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,69086000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114085000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116138000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q1,2009-09-26,2009-12-25,2011-02-09 16:27:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29623000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29623000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,213798000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29630000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,26724000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25248000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,118000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81720000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,132078000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,112000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1954000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1851000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,133929000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,47610000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86319000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86319000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,85898000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113985000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115995000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q2,2009-12-26,2010-03-26,2011-05-10 14:57:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,230269000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,230269000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30462000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30462000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,199807000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29165000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,36527000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27513000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1068000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,103867000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,95940000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,392000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1879000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,655000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2142000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98082000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34394000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63688000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63688000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,236000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63452000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113254000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115282000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q3,2010-03-27,2010-06-25,2010-07-29 16:18:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,227807000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,227807000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26343000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,9594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35937000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,191870000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32676000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,36525000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29417000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5655000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94679000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,97191000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,114000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1633000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-88000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1431000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98622000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35295000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63327000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63327000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1684000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65011000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113452000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115388000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2010.0,Q4,2010-06-26,2010-09-24,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,242712000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,242712000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29139000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29139000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,213573000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37042000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,38217000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28327000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,785000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104371000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,109202000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,283000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1614000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,533000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1864000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,111066000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24301000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86765000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86765000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,378000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86387000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112035000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113713000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q1,2010-09-25,2010-12-31,2011-02-09 16:27:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,250026000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,250026000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28457000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28457000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,221569000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35155000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,37545000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28399000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101099000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,120470000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1953000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,156000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2024000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,122494000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40012000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82482000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,82482000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,82061000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112140000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113346000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q2,2011-01-01,2011-04-01,2011-05-10 14:57:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,218999000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,218999000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27933000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27933000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,191066000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32397000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,36726000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34086000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-48000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,103161000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87905000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-690000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1670000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,186000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2546000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,90451000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28404000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62047000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62047000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,299000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61748000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111494000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112349000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112300000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q3,2011-04-02,2011-07-01,2011-08-04 16:31:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,249328000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,249328000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25642000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25642000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,223686000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33039000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,42714000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33108000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2669000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111530000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,112156000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-705000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3739000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4476000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,116632000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,37344000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,79288000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,79288000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,217000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,79071000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111444000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112554000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2011.0,Q4,2011-07-02,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,233378000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,233378000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20410000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20410000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,212968000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35465000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,43016000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32826000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,368000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111675000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,101293000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1737000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1911000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,103204000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29838000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73366000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73366000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,207000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73159000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108884000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109443000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q1,2011-10-01,2011-12-30,2012-02-03 17:24:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,260259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,260259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23592000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23592000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,236667000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37281000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,43194000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34236000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,910000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,115621000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,121046000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1414000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1469000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,122515000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34198000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88317000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88317000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,197000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88120000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108415000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109170000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108800000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q2,2011-12-31,2012-03-30,2012-05-08 13:38:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207872000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207872000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21031000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21031000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,186841000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36859000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,46819000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35123000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-85000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,118716000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,68125000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1513000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,709000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2196000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70321000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18915000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51406000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51406000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-123000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51529000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106328000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107202000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q3,2012-03-31,2012-06-29,2012-08-08 16:42:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,231505000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,231505000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26994000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26994000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,204511000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39570000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,55457000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37958000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-2000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132983000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,71528000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,139000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1747000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-185000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1423000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72951000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20906000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52045000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52045000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,551000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51494000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106926000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107541000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107000000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2012.0,Q4,2012-06-30,2012-09-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,236602000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,236602000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25605000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25605000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,210997000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43108000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,58421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42436000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,143965000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67032000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1339000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,713000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2027000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69059000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17582000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51477000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51477000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,128000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51349000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102361000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103523000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q1,2012-09-29,2012-12-28,2013-02-06 16:35:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,249346000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,249346000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23283000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23283000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,226063000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41803000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,58130000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41948000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,141881000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84182000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,402000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,904000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,690000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,84872000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22633000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,62239000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,62239000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,328000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61911000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101638000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102680000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q2,2012-12-29,2013-03-29,2013-05-02 11:04:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207074000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207074000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24340000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24340000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,182734000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38413000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,58528000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42915000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5930000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,145786000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36948000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,77000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,820000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,156000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,899000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37847000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7345000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30502000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30502000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,286000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30216000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101751000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103031000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q3,2013-03-30,2013-06-28,2013-07-31 16:45:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,216652000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,216652000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23491000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23491000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,193161000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38646000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,56024000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41447000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-56000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,136061000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57100000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,71000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,785000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1054000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1768000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58868000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12784000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46084000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46084000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,289000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45795000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101879000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102788000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101800000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2013.0,Q4,2013-06-29,2013-09-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,231277000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,231277000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21382000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21382000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,209895000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41908000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,60379000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44463000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3215000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,149965000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59930000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,112000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,654000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,229000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,771000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60701000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15455000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45246000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45246000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,731000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44515000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101750000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103192000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q1,2013-09-28,2013-12-27,2014-01-29 17:03:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278592000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278592000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17505000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17505000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,261087000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46457000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,64828000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44798000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,86000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156169000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,104918000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,93000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,920000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2823000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1996000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,102922000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26373000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76549000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76549000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,681000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75868000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102291000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103934000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q2,2013-12-28,2014-03-28,2014-04-30 15:54:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,223350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,223350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18869000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18869000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,204481000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44205000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,63602000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46786000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-688000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,153905000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50576000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,251000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,959000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,530000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1238000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51814000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11251000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40563000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40563000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,784000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39779000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103942000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102000000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q3,2014-03-29,2014-06-27,2015-07-30 20:14:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,226957000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,226957000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12420000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12420000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214537000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45534000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,63838000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47081000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-210000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,156243000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58294000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-639000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,811000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,918000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2368000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60662000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14300000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46362000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46362000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,421000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45941000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102151000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103632000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102000000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2014.0,Q4,2014-06-28,2014-09-26,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,234238000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,234238000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19410000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19410000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214828000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44716000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,68018000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-39000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,161289000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53539000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-108000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,777000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54316000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12379000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41937000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,41937000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,580000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,41357000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102303000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104275000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q1,2014-09-27,2014-12-26,2016-02-05 12:32:18+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,271950000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,271950000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25149000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25149000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,246801000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45653000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,65940000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56601000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,168194000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78607000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1091000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,218000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1278000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,79885000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21353000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58532000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58532000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,558000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,57974000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102509000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103904000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q2,2014-12-27,2015-03-27,2016-05-04 16:10:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,231702000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,231702000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24880000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24880000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206822000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45587000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,70782000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45508000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,161877000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44945000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1453000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1049000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2433000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47378000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11522000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35856000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35856000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,35506000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102670000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104105000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q3,2015-03-28,2015-06-26,2016-08-02 16:46:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.2
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,232748000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,232748000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25377000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25377000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,207371000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46220000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,74434000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50621000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-41000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171234000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36137000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,68000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1100000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,27034000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28066000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64203000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17288000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46915000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46915000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,362000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46553000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102354000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103862000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2015.0,Q4,2015-06-27,2015-09-25,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240814000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,240814000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29766000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29766000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,211048000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44078000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,74454000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53328000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171860000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39188000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1297000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-972000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,296000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39484000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8473000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31011000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31011000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,110000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30901000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100734000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101931000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q1,2015-09-26,2016-01-01,2017-02-01 19:18:10+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.24
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,274340000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,274340000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24373000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24373000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,249967000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42482000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,71815000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52088000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1255000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167640000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,82327000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1250000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,279000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1496000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83823000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16278000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67545000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,67545000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,147000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,67398000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100456000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101555000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100600000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q2,2016-01-02,2016-04-01,2017-05-03 16:58:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,277587000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,277587000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24621000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24621000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,252966000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42570000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,74234000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54977000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-10000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171771000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,81195000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1464000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-849000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,589000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,81784000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18017000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63767000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63767000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,139000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63628000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100533000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102677000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101000000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q3,2016-04-02,2016-07-01,2017-08-02 18:02:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,232997000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,232997000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30222000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30222000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,202775000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39724000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,74764000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59214000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-12000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,173690000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29085000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1673000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,92000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1728000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30813000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6734000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24079000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24079000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,146000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23933000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100717000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102424000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2016.0,Q4,2016-07-02,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,266267000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,266267000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29967000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29967000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,236300000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41540000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,71175000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57518000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,170233000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,66067000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1814000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-199000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1589000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,67656000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14082000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53574000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,53574000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,53374000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101483000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103876000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q1,2016-10-01,2016-12-30,2018-01-31 17:23:50+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,267474000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,267474000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26977000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26977000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,240497000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43253000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,75620000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58341000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,177214000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63283000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2186000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,762000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2911000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66194000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15467000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50727000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50727000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,137000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50590000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101787000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103883000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101200000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q2,2016-12-31,2017-03-31,2018-05-02 17:24:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,305665000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,305665000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32125000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32125000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,273540000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44497000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,73480000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59631000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,177608000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,95932000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2511000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2109000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,371000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,96303000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20117000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76186000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76186000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,143000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76043000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101905000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104222000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q3,2017-04-01,2017-06-30,2018-08-01 16:51:40+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1320948000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1320948000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,147989000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,147989000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1172959000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42396000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,76386000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57822000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,961648000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,12856000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1151108000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21851000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3066000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,108000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3141000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24992000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1627000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26619000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26619000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,145000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26474000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101784000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103286000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2017.0,Q4,2017-07-01,2017-09-29,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,299527000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,299527000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30893000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30893000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,268634000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48285000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,70149000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,56444000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-197000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,174681000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,93953000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,35000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3781000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1152000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,96547000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,149705000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53158000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53158000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,144000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53302000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102552000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102552000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q1,2017-09-30,2017-12-29,2019-01-31 17:46:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,299722000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,299722000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31027000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31027000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,268695000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50747000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,74019000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59493000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-167000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,184092000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84603000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3892000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-684000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3179000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,87782000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22432000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65350000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,134000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65216000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103771000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107001000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q2,2017-12-30,2018-03-30,2019-05-08 16:59:39+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,214780000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,214780000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34383000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34383000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,180397000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47893000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,79834000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60357000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-82000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,188002000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7605000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,87000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5487000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3603000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1797000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5808000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9067000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,143000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3116000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103836000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106950000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103900000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q3,2018-03-31,2018-06-29,2019-08-02 16:47:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240571000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,240571000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31259000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,209312000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50498000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,85760000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,196758000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12554000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,47000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5810000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-464000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5299000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17853000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9001000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26854000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26854000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,138000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26716000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103377000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106978000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2018.0,Q4,2018-06-30,2018-09-28,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.83
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,338258000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,338258000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36575000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36575000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,301683000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47416000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,92694000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58625000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,198753000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,102930000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,32000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7494000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-390000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7072000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,110002000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36400000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73602000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73575000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,135000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73440000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102141000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104587000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.7
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102000000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q2,2018-12-29,2019-03-29,2020-05-04 17:08:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,302159000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,302159000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39690000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39690000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,262469000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54183000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,83390000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60408000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,30232000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,228213000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34256000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6551000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1022000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7544000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41800000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2163000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39637000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39637000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,63000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39574000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101218000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103717000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101500000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q3,2019-03-30,2019-06-28,2019-08-02 16:47:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.19
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-263828000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-263828000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-516695000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-516695000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,252867000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53013000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,82149000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60191000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6294000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,201647000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51220000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,64000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5689000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-594000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5031000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,56251000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12339000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43912000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43935000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,17000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43918000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101629000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104572000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101700000.0
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Dolby Laboratories Inc,DLB,549300X04FB2QPCJ5J24,0001308547,2019.0,Q4,2019-06-29,2019-09-27,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.79
